1-94536311-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001993.5(F3):c.213-147A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0419 in 711,428 control chromosomes in the GnomAD database, including 849 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.038 ( 176 hom., cov: 32)
Exomes 𝑓: 0.043 ( 673 hom. )
Consequence
F3
NM_001993.5 intron
NM_001993.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.523
Publications
17 publications found
Genes affected
F3 (HGNC:3541): (coagulation factor III, tissue factor) This gene encodes coagulation factor III which is a cell surface glycoprotein. This factor enables cells to initiate the blood coagulation cascades, and it functions as the high-affinity receptor for the coagulation factor VII. The resulting complex provides a catalytic event that is responsible for initiation of the coagulation protease cascades by specific limited proteolysis. Unlike the other cofactors of these protease cascades, which circulate as nonfunctional precursors, this factor is a potent initiator that is fully functional when expressed on cell surfaces, for example, on monocytes. There are 3 distinct domains of this factor: extracellular, transmembrane, and cytoplasmic. Platelets and monocytes have been shown to express this coagulation factor under procoagulatory and proinflammatory stimuli, and a major role in HIV-associated coagulopathy has been described. Platelet-dependent monocyte expression of coagulation factor III has been described to be associated with Coronavirus Disease 2019 (COVID-19) severity and mortality. This protein is the only one in the coagulation pathway for which a congenital deficiency has not been described. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0548 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| F3 | ENST00000334047.12 | c.213-147A>G | intron_variant | Intron 2 of 5 | 1 | NM_001993.5 | ENSP00000334145.7 | |||
| F3 | ENST00000370207.4 | c.213-147A>G | intron_variant | Intron 2 of 4 | 1 | ENSP00000359226.4 | ||||
| F3 | ENST00000480356.1 | n.831-147A>G | intron_variant | Intron 3 of 4 | 5 | |||||
| F3 | ENST00000478217.5 | n.-147A>G | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0380 AC: 5782AN: 152080Hom.: 176 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
5782
AN:
152080
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0430 AC: 24037AN: 559230Hom.: 673 AF XY: 0.0418 AC XY: 12280AN XY: 293918 show subpopulations
GnomAD4 exome
AF:
AC:
24037
AN:
559230
Hom.:
AF XY:
AC XY:
12280
AN XY:
293918
show subpopulations
African (AFR)
AF:
AC:
115
AN:
14956
American (AMR)
AF:
AC:
595
AN:
24088
Ashkenazi Jewish (ASJ)
AF:
AC:
349
AN:
15352
East Asian (EAS)
AF:
AC:
1
AN:
32602
South Asian (SAS)
AF:
AC:
752
AN:
51512
European-Finnish (FIN)
AF:
AC:
2437
AN:
31628
Middle Eastern (MID)
AF:
AC:
14
AN:
2202
European-Non Finnish (NFE)
AF:
AC:
18601
AN:
357034
Other (OTH)
AF:
AC:
1173
AN:
29856
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1128
2255
3383
4510
5638
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
214
428
642
856
1070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0380 AC: 5781AN: 152198Hom.: 176 Cov.: 32 AF XY: 0.0384 AC XY: 2858AN XY: 74416 show subpopulations
GnomAD4 genome
AF:
AC:
5781
AN:
152198
Hom.:
Cov.:
32
AF XY:
AC XY:
2858
AN XY:
74416
show subpopulations
African (AFR)
AF:
AC:
382
AN:
41536
American (AMR)
AF:
AC:
454
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
80
AN:
3472
East Asian (EAS)
AF:
AC:
2
AN:
5188
South Asian (SAS)
AF:
AC:
70
AN:
4822
European-Finnish (FIN)
AF:
AC:
885
AN:
10580
Middle Eastern (MID)
AF:
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
AC:
3829
AN:
68000
Other (OTH)
AF:
AC:
72
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
286
572
857
1143
1429
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
26
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.